Stay updated on Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.

Latest updates to the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe record history now shows a new revision entry labeled v3.6.6, replacing the earlier v3.6.5. This reflects an update to the study record's version history rather than substantive study data.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe record history now includes a new version entry, Revision: v3.6.5. The previous Revision: v3.6.4 has been removed, reflecting an update to the log rather than study content.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision v3.6.4 was added to the record history and the previous revision v3.6.3 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedThe record history now shows the latest revision as v3.6.3, indicating the page was updated. The previous revision v3.6.1 is removed from the history view.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry (v3.6.1) has been added to the Study Record History, superseding the prior revision (v3.6.0). This reflects an updated release of the study record on the ClinicalTrials.gov history page.SummaryDifference0.1%

- Check97 days agoChange DetectedThe record now shows that recruitment has ended with a banner stating 'No longer looking for participants'. A new revision tag v3.6.0 was added, replacing the previous v3.5.5.SummaryDifference0.5%

Stay in the know with updates to Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.